SCHEMBL7833743

SCHEMBL7833743

CC(C)(COCc1ccccc1)CN1CCN(c2ccccc2OCC(F)(F)F)CC1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 10/20 0.57
ADRA1B P35368 10/20 0.57
ADRA1D P25100 9/20 0.57
DRD2 P14416 1/20 0.48
DRD4 P21917 1/20 0.48
DRD3 P35462 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
HTR1A P08908 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
SLC6A3 Q01959 1/20 0.44
HSP90AB1 P08238 1/20 0.42
MEN1 O00255 1/20 0.42
TP53 P04637 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7830825 0.83 ADRA1A (0.62) ADRA1AADRA1BADRA1DDRD2DRD4
SCHEMBL7832834 0.83 ADRA1A (0.62) ADRA1AADRA1BADRA1DDRD2DRD4
SCHEMBL7835975 0.81 RAB9A (0.46) ADRA1AADRA1BADRA1DCYP3A4CYP2C9
SCHEMBL7831996 0.76 ADRA1A (0.68) ADRA1AADRA1BADRA1DDRD2DRD4
SCHEMBL24712880 0.74 DRD2 (0.59) ADRA1AADRA1BADRA1DDRD2DRD4
SCHEMBL24712881 0.71 ADRA1A (0.49) ADRA1AADRA1BADRA1DDRD2DRD4
SCHEMBL7835709 0.71 ADRA1A (0.60) ADRA1AADRA1BADRA1DDRD2DRD3
SCHEMBL6771682 0.71 ADRA1A (0.60) ADRA1AADRA1BADRA1DDRD2DRD3
SCHEMBL9028727 0.71 ADRA1A (0.60) ADRA1AADRA1BADRA1DDRD2DRD3
SCHEMBL5240191 0.70 L3MBTL1 (0.49) ADRA1AADRA1BADRA1DCYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748800-B1 Pyrimidinedione, pyrimidinetrione, triazinedione derivatives as alpha-1-adrenergic receptor antagonists HOFFMANN LA ROCHE (CH) 2001-05-09 EP disclosed
US-5859014-A USEFUL IN TREATMENT OF DISEASES INVOLVING DIRECTLY OR INDIRECTLY AN OBSTRUCTION OF THE LOWER URINARY TRACT, SUCH ASBENIGN PROSTATE HYPERPLASIA SYNTEX (U.S.A.) INC. (US) 1999-01-12 US disclosed
EP-0748800-A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists F. HOFFMANN-LA ROCHE AG (CH) 1996-12-18 EP disclosed